Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection*, by sex, race/ethnicity, age group, and case criteria — Emerging Infections Program (EIP) Enhanced Viral Hepatitis Surveillance, 2009
Category
|
CO No. (%) |
CT No. (%) |
MN No. (%) |
NM No. (%) |
NY State No. (%) |
NY City No. (%) |
San Francisco No. (%) |
Total No. (%) |
---|---|---|---|---|---|---|---|---|
Sex
|
||||||||
Female
|
97 (45.1) | 177 (37.8) | 366 (49.5) | 28 (49.1) | 588 (39.9) | 3,380 (44.1) | 444 (47.3) | 5,080 (44.0) |
Male
|
118 (54.9) | 291 (62.2) | 369 (50.0) | 29 (50.9) | 885 (60.0) | 4,286 (55.9) | 490 (52.2) | 6,468 (56.0) |
Missing/
Unknown* |
0 (0.0) | 0 (0.0) | 4 (0.5) | 0 (0.0) | 1 (0.1) | 1 (0.0) | 4 (0.4) | 10 (0.1) |
Race/Ethnicity
|
||||||||
American Indian/
Alaska Native |
2 (0.9) | 0 (0.0) | 5 (0.7) | 0 (0.0) | 5 (0.3) | 3 (0.0) | 1 (0.1) | 16 (0.1) |
Asian/Pacific
Islander |
75 (34.9) | 166 (35.5) | 266 (36.0) | 16 (28.1) | 435 (29.5) | 1,332 (17.4) | 582 (62.1) | 2,872 (24.8) |
Black,
non-Hispanic |
44 (20.5) | 81 (17.3) | 214 (28.0) | 6 (10.5) | 284 (19.3) | 548 (7.2) | 17 (1.8) | 1,194 (10.3) |
White,
non-Hispanic |
37 (17.2) | 91 (19.4) | 49 (6.6) | 14 (24.6) | 245 (16.6) | 139 (1.8) | 36 (3.8) | 611 (5.3) |
Hispanic
|
10 (4.7) | 44 (9.4) | 3 (0.4) | 9 (15.8) | 89 (6.0) | 117 (1.5) | 13 (1.4) | 285 (2.5) |
Other
|
6 (2.8) | 4 (0.9) | 9 (1.2) | 0 (0.0) | 18 (1.2) | 0 (0.0) | 14 (1.5) | 51 (0.4) |
Missing/
Unknown |
41 (19.1) | 82 (17.5) | 193 (26.1) | 12 (21.1) | 398 (27.0) | 5,528 (72.1) | 275 (29.3) | 6,529 (56.5) |
Age group (yrs)
|
||||||||
0-14
|
7 (3.3) | 10 (2.1) | 25 (3.4) | 0 (0.0) | 36 (2.4) | 67 (0.9) | 5 (0.5) | 150 (1.3) |
15-24
|
25 (11.6) | 29 (6.2) | 111 (15.0) | 5 (8.8) | 119 (8.1) | 797 (10.4) | 34 (3.6) | 1,120 (9.7) |
25-39
|
96 (44.7) | 177 (37.8) | 319 (43.2) | 15 (26.3) | 461 (31.3) | 3,203 (41.8) | 269 (28.7) | 4,540 (39.3) |
40-54
|
52 (24.2) | 170 (36.3) | 183 (24.8) | 20 (35.1) | 543 (36.8) | 2,378 (31.0) | 327 (34.9) | 3,673 (31.8) |
≥55
|
35 (16.3) | 82 (17.5) | 101 (13.7) | 17 (29.8) | 315 (21.4) | 1,222 (15.9) | 302 (32.2) | 2,074 (17.9) |
Missing*
|
0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.1) | 1 (0.0) |
Country of Birth
|
||||||||
United States
|
28 (13.0) | 50 (10.7) | 33 (4.5) | U† | 60 (4.1) | 13 (0.2) | 35 (3.7) | 219 (1.9) |
Other
|
126 (58.6) | 187 (40.0) | 448 (60.6) | U | 1,236 (83.9) | 193 (2.5) | 233 (24.8) | 2,423 (21.1) |
Missing/
Unknown |
61 (28.4) | 231 (49.4) | 258 (34.9) | U | 178 (12.1) | 7,461 (97.3) | 670 (71.4) | 8,859 (77.0) |
Case criteria§
|
||||||||
Hepatitis B surface
antigen(HBsAg) |
203 (94.4) | 460 (98.3) | 718 (97.2) | U | 1,426 (96.7) | 7,329 (95.6) | 892 (95.1) | 11,028 (95.9) |
Hepatitis B e-
antigen(HBeAg) |
21 (9.8) | 65 (13.9) | 150 (20.3) | U | 251 (17.0) | 1,591 (20.8) | 102 (10.9) | 2,180 (19.0) |
HBV-DNA
|
32 (14.9) | 156 (33.3) | 437 (58.1) | U | 807 (54.8) | 5,145 (67.1) | 506 (53.9) | 7,083 (61.6) |
Total new
reported cases |
215 | 468 | 739 | 57 | 1,474 | 7,667 | 938 | 11,558 |
Estimated 2009
population |
5,024,748 | 3,518,288 | 5,266,214 | 2,009,671 | 4,265,336 | 8,391,881 | 815,358 | 29,291,496 |
Rate¶
|
4.3 | 13.3 | 14.0 | 2.8 | 34.6 | 91.4 | 115.0 | 39.5 |
* “Missing” refers to case reports for which data are absent, whereas “unknown” refers to case reports for which an attempt was made to capture this information, but no valid response was provided.
†U=No data available for reporting.
§More than one laboratory result can accompany each case report.
¶Rate per 100,000 population.